Keyphrases
Healthy Controls
100%
Endothelial Function
100%
Patients with Coronary Artery Disease
100%
Immunoglobulin G
100%
Anticardiolipin Antibodies
100%
Endothelial Dysfunction
75%
Immunoglobulin
75%
Immunoglobulin M
75%
Patients with Cardiovascular Diseases
75%
Flow-mediated Dilation
50%
Oxidized Low-density Lipoprotein (ox-LDL)
50%
Antinuclear Antibodies
50%
Vasodilatation
50%
Nitroglycerin
50%
β2-glycoprotein I (β2GPI)
50%
Single Center
25%
Between-group
25%
Prognostic Value
25%
Heart Disease
25%
Autoantibodies
25%
Cerebrovascular Disease
25%
Coronary Disease
25%
Anticardiolipin
25%
Antiphospholipid Antibodies
25%
Antiphospholipid Autoantibodies
25%
Smooth muscle Function
25%
Medicine and Dentistry
Coronary Artery Disease
100%
Endothelial Function
100%
Immunoglobulin G
100%
Cardiolipin Antibody
100%
Anti-Cardiolipin Antibodies
100%
Cardiovascular Disease
42%
Atherosclerosis
42%
Immunoglobulin M
42%
Endothelial Dysfunction
42%
Immunoglobulin A
42%
Glyceryl Trinitrate
28%
Flow Mediated Dilatation
28%
Vasodilatation
28%
Glycoprotein
28%
Antinuclear Antibody
28%
Autoantibodies
28%
Oxidized Low Density Lipoprotein
28%
Prospective Study
14%
Heart Disease
14%
Antiphospholipid Antibody
14%
Cerebrovascular Disease
14%
Smooth Muscle
14%
Muscle Function
14%
Immunology and Microbiology
Immunoglobulin G
100%
Coronary Artery
100%
Cardiolipin Antibody
100%
Anti-Cardiolipin Antibodies
100%
Immunoglobulin M
42%
Normal Human
42%
Immunoglobulin A
42%
Atherosclerosis
42%
Dilatation
28%
Vasodilatation
28%
Glycoprotein
28%
Autoantibodies
28%
Antinuclear Antibody
28%
Smooth Muscle
14%
Muscle Function
14%
Phospholipid Antibody
14%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Disease
100%
Cardiolipin Antibody
100%
Immunoglobulin G
100%
Normal Human
42%
Cardiovascular Disease
42%
Immunoglobulin A
42%
Atherosclerosis
42%
Immunoglobulin M
42%
Endothelial Dysfunction
42%
Glyceryl Trinitrate
28%
Oxidized Low Density Lipoprotein
28%
Antinuclear Antibody
28%
Autoantibodies
28%
Glycoprotein
28%
Heart Disease
14%
Prospective Study
14%
Cerebrovascular Disease
14%
Antiphospholipid Antibody
14%
Biochemistry, Genetics and Molecular Biology
Anti-Cardiolipin Antibodies
100%
Immunoglobulin G
100%
Normal Human
42%
Immunoglobulin A
42%
Immunoglobulin M
42%
Glycoprotein
28%
Low-Density Lipoprotein
28%
Dilatation
28%
Autoantibodies
28%
Vasodilatation
28%
Prospective Study
14%
Antiphospholipid Antibody
14%
Muscle Function
14%